Cannabis products appear to have “beneficial effects” for people struggling with the symptoms of chronic pain, according to a new study— with the results indicating relief from both intoxicating and nonintoxicating cannabinoids.
Researchers affiliated with the University at Buffalo, University of Michigan Medical School and MoreBetter recruited 64 people with fibromyalgia, 25 with rheumatoid arthritis and 75 with osteoarthritis of the knee and/or hip to participate in the trial.
The participants, all of whom were California residents, were randomly assigned to take one of three different cannabinoid products via oral capsule over 12 weeks and report their pain, mental health, cognitive functioning and physical functioning using questionnaires.
Product 1 contained 12.5 mg cannabidiol (CBD) and 12.5 mg tetrahydrocannabinol. Product 2 had 10 mg tetrahydrocannabinolic acid, 10 mg cannabidiolic acid (CBDa), 5 mg cannabigerol and 3 mg cannabichromene. Product 3 was comprised of 10 mg CBD and 10 mg CBDa.
“There were significant improvements across all symptoms except cognitive function abilities,” the paper, published in the journal Clinical Therapeutics, says. “Effects ranged from small to large, with most not differing in magnitude across product or type of chronic pain.”
“Participants reported substantial improvements in sleep quality, mental health conditions, and general
Read full article on Marijuana Moment
